Skip to main content
. 2020 Mar 12;38(5):1580–1587. doi: 10.1007/s10637-020-00914-5

Table 3.

Frequency of adverse events related to dDAVP administration

Adverse event Number of events
Grade 1 Grade 2 Grade 3

Hyponatremia

Increased blood pressure

5

4

0

3

5

2

Muscle cramps

Facial flushing

Hypokalemia

Headache

Increased transaminases

Arthralgia

Depressed level of consciousness

Amnesia

5

4

2

2

1

1

1

1

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Total 26 (70.3%) 4 (10.8%) 7 (18.9%)